Objectives: The precise evaluation of adolescent growth spurt is necessary for numerous clinical research studies of growth disorders and treatments. The objectives of our study were: (1) to evaluate the reliability of clinicians’ ‘manual’ evaluation of the adolescent growth spurt from a collected series of height data, and (2) to construct an automated algorithm to determine the duration of the two phases of growth in health and disease (spurt and final slow growth) independent of clinical pubertal stages. Methods: One hundred and seventy-four growth curves of normally growing, GH-deficient and Turner’s syndrome subjects were presented twice to 2 experienced clinicians. Disagreement between evaluations and clinicians were settled to obtain a ‘consensual gold standard’ evaluation versus which the algorithm was assessed. Kappa statistics and Bland-Altman analyses were used to evaluate the reliability and agreement of the evaluations. Results: The reliability of ‘manual’ evaluation of adolescent growth spurt from collected series of height data appeared to be poor. Conversely, the developed algorithm is perfectly reliable and satisfactorily valid. Discrepancies with the clinical consensual gold standard were always fewer than the discrepancies between the expert clinicians, and were observed in similarly difficult curves. Conclusion: The developed algorithm may be useful for diverse clinical and biological research applications in children with growth disorders. This study also confirms the value of a comprehensive investigation of growth during adolescence independent of clinical staging.

1.
Tanner JM, Whitehouse RH, Takaishi M: Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child 1966;41:454–471.
2.
Tanner JM, Whitehouse RH, Takaishi M: Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II. Arch Dis Child 1966;41:613–635.
3.
Tanner JM, Whitehouse RH, Marubini E, Resele LF: The adolescent growth spurt of boys and girls of the Harpenden growth study. Ann Hum Biol 1976;3:109–126.
4.
Largo RH, Prader A. Pubertal development in Swiss girls. Helv Paediatr Acta 1983;38:229–243.
5.
Largo RH, Prader A: Pubertal development in Swiss boys. Helv Paediatr Acta 1983;38:211–228.
6.
Hagg U, Karlberg J, Taranger J: The timing of secondary sex characters and their relationship to the pubertal maximum of linear growth in girls. Swed Dent J 1991;15:271–278.
7.
Hagg U, Taranger J: Maturation indicators and the pubertal growth spurt. Am J Orthod 1982;82:299–309.
8.
Abbassi V: Growth and normal puberty. Pediatrics 1998;102:507–511.
9.
Coste J, Letrait M, Carel JC, Tresca JP, Chaussain JL, Chatelain P, Rochiccioli P, Job JC: Long-term results of growth hormone in short-stature children: A population register-based study. BMJ 1997;315:708–712.
10.
Sempé M, Pedron G, Roy-Pernot MP: Auxologie, méthodes et séquences, Paris, Théraplix, 1979.
11.
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in girls. Arch Dis Child 1969;44:291–303.
12.
Marshall WA, Tanner JM: Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–24.
13.
Greulich WW, Pyle SI: Radiographic Atlas of Skeletal Development of the Hand and Wrist. New York, Stanford University Press, 1970.
14.
Altman DG, Bland JM: Measurement in medicine: The analysis of method comparison studies. Statistician 1983;32:307–317.
15.
Fleiss J: Statistical Methods for Rates and Proportions. New York, Wiley, 1981.
16.
Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 1977;33:159–174.
17.
Efron B, Tibshirani R: Bootstrap methods for standard errors, confidence intervals and other methods of statistical accuracy. Stat Sci 1986;1:54–75.
18.
SAS Institute: SAS/STAT User’s Guide, version 6. Cary, SAS Institute, 990, pp 893–896.
19.
Ranke MB, Price DA, Albertsson-Wikland K, Maes M, Lindberg A: Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 patients of the Kabi Pharmacia International Growth Study. Horm Res 1997;48:62–71.
20.
Rotteveel J, de Ridder C, Schoute E, Delemarre-van de Waal HA: Androstenedione, dehydroepiandrosterone sulfate, and estradiol levels throughout female puberty: Relation to height velocity. Horm Res 1997;48:263–267.
21.
Martha PM Jr, Reiter EO: Pubertal growth and growth hormone secretion. Endocrinol Metab Clin North Am 1991;20:165–182.
22.
Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T: Analysis of 24-hour growth hormone profiles in healthy boys and girls of normal stature: Relation to puberty. J Clin Endocrinol Metab 1994;78:1195–1201.
23.
Gasser T, Kohler W, Muller HG, Kneip A, Largo R, Molinari L, Prader A: Velocity and acceleration of height growth using kernel estimation. Ann Hum Biol 1984;11:397–411.
24.
Ledford AW, Cole TJ: Mathematical models of growth in stature throughout childhood. Ann Hum Biol 1998;25:101–115.
25.
Gasser T, Sheehy A, Largo RH: Statistical characterization of the pubertal growth spurt. Ann Hum Biol 2001;28:395–402.
26.
Taranger J, Hagg U: The timing and duration of adolescent growth. Acta Odontol Scand 1980;38:57–67.
27.
Berkey CS, Dockery DW, Wang X, Wypij D, Ferris B Jr: Longitudinal height velocity standards for US adolescents. Stat Med 1993;12:403–414.
28.
Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA: Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995;73:17–24.
29.
Wheeler MD: Physical changes of puberty. Endocrinol Metab Clin North Am 1991;20:1–14.
30.
Cole T: Methodology for the Analysis of Longitudinal Height Data during Puberty. Kabi International Growth Study, 1993, Report No 10, pp 37–44.
31.
Haeusler G, Schemper M, Frisch H, Blumel P, Schmitt K, Plochl E: Spontaneous growth in Turner syndrome: Evidence for a minor pubertal growth spurt. Eur J Pediatr 1992;151:283–287.
32.
Butler GE, McKie M, Ratcliffe SG: The cyclical nature of prepubertal growth. Ann Hum Biol 1990;17:177–198.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.